Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics - Wikidata - awgldk - TriplyDB

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

http://www.wikidata.org/entity/Q33826366

about

The arsenal of pathogens and antivirulence therapeutic strategies for disarming them Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms How type 1 fimbriae help Escherichia coli to evade extracellular antibiotics HipBA-promoter structures reveal the basis of heritable multidrug tolerance A Dormant Microbial Component in the Development of Preeclampsia High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Escherichia coli biofilm formation and recurrences of urinary tract infections in children.Cystitis: from urothelial cell biology to clinical applications.Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.Transcriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective Antibiotics Antibiotic Resistance and Virulence Phenotypes of Recent Bacterial Strains Isolated from Urinary Tract Infections in Elderly Patients with Prostatic Disease.Phylogenetic grouping and pathotypic comparison of urine and fecal Escherichia coli isolates from children with urinary tract infection.Uropathogenic Escherichia coli induces serum amyloid a in mice following urinary tract and systemic inoculation.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors.Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli Determinants of antimicrobial resistance in Escherichia coli strains isolated from faeces and urine of women with recurrent urinary tract infections.Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992-2011).Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli.Community behavior and amyloid-associated phenotypes among a panel of uropathogenic E. coli Enterococcus faecalis subverts and invades the host urothelium in patients with chronic urinary tract infection Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.Characterization of the Vibrio cholerae extracellular matrix: a top-down solid-state NMR approach.Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5 In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli.Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.The Biology of the Escherichia coli Extracellular Matrix Bioactive ZnO Coatings Deposited by MAPLE-An Appropriate Strategy to Produce Efficient Anti-Biofilm Surfaces.Dimethyl sulfoxide and ethanol elicit increased amyloid biogenesis and amyloid-integrated biofilm formation in Escherichia coli.Uropathogenic E. coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2).Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library.Carbon monoxide releasing molecule-2 (CORM-2) inhibits growth of multidrug-resistant uropathogenic Escherichia coli in biofilm and following host cell colonization.Efficacy of ceftobiprole Medocaril against Enterococcus faecalis in a murine urinary tract infection model Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo.

P2860

Q26745604-8C2352C5-939A-4F85-A262-A76B284D9FD9 Q26799248-DEC59A63-D498-41B3-BB40-B53FE09039E6 Q27303781-7BED46A7-DD36-4C68-8108-8E6DF8B64484 Q27701668-BDBA1A7F-3628-4A8E-A9EC-79A5A84E3D5F Q28069689-C0890C09-C48E-4E2F-8048-4E1129642D18 Q28474866-0E6C0E07-0E9C-4AD0-9182-4799E599C792 Q30424697-8E661D7E-6917-4622-8F7D-3545A1587035 Q31135716-167C21D4-2E6D-4BF2-BAF0-B4ADB1C409EB Q33616113-081094D0-99C0-455A-A58F-A05A00FA3AD8 Q33622796-E0B59F8A-182E-482A-8658-6497D4A0E788 Q33790123-CACE2731-1EA4-4137-88A4-0387B24A032A Q33847272-44272B3E-234C-485A-9A74-3AB26A5A03DA Q34198323-659532B0-5ED9-4ED7-845D-63F2765A18C3 Q34200173-C1BEB135-0718-46A5-8F6E-57FEB981641D Q34297628-D5FA7BD8-D22F-40A4-87FE-0B9E676B720D Q34415785-4D54D377-615B-4019-8A27-2E3FAD4A04E5 Q34440664-CDC491A5-26D9-421D-A81A-6FFE9A922944 Q34482888-7C496EBC-A54C-446F-9F0B-501974DBB1D9 Q34727309-6CE55F93-1FB8-4A5A-A5FC-9E41DD2FC4FC Q35025542-B22C2023-3C63-480E-93DE-762B1179636F Q35044837-0F8A9227-13D6-490F-9340-D7211C853FBE Q35074374-9C6E7A9B-0041-4B3F-9461-9DE73525ECDF Q35098186-BE5C2E2F-AD3D-4B46-A049-F951B03F6B5C Q35131385-8655C336-10A9-4380-9249-2260D5804577 Q35273075-0FE3557C-989E-4008-B019-E323F6E75016 Q35523883-EC56AD3C-DFB4-4DEC-9E77-ECAAE5C5E8E2 Q35662142-C6B197D8-2067-415C-8679-0D3CAB771F42 Q35664689-01DF28DE-DE87-42E1-B8AF-4F0D2946EFD8 Q35677483-E19DCEEC-6560-43CA-9FC5-FFDFC55308C0 Q35697535-EFCB2F53-0E9F-401D-8738-59C989A4403F Q35865857-82D82405-03BC-4A75-8E05-8D825E2BC153 Q35927526-7F97C425-33EC-4002-B357-84C09A3E74C5 Q35941073-B3AF057B-1EEA-4077-8CE9-C479E12DFDAD Q35952887-B134F65E-8C52-4F48-AB27-7B42B9159AC7 Q35960915-7BBC58A7-7F57-4C10-9969-3FD473A11FBA Q35973159-6CD16FF3-E8D7-40C5-9C4E-0804A671FB10 Q35986311-08B182D5-E48D-4CB5-8908-11F80ACF5448 Q36018587-70865725-DF83-4557-81ED-97E64EE744DF Q36032748-CE39C929-59F6-4ABB-AE0B-EC5717CCF58B Q36079542-A9D35A35-22D5-4404-9E95-33170EEA1FA9

P2860

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

http://www.wikidata.org/entity/Q33826366

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

@ast

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

@en

type

label

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

@ast

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

@en

prefLabel

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

@ast

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

@en

P1433

Q33826366-622AF67A-01A6-4611-AAAE-26FBE21C165D

P1476

Q33826366-F604D7C6-E962-4292-93BA-276F1047D168

P2093

Q33826366-7051A767-2DA3-4D7D-9997-D561E349D6F0

Q33826366-A08813DD-26FD-4DBB-823F-770CF7CE4A47

P2860

Q33826366-05DA1888-D122-4FC8-B390-4C4D9E801668

Q33826366-079BE12C-DFB9-4C2F-A120-E572B070A76F

Q33826366-09D0F19D-02D0-4F45-A6D8-D3BEE7BA8DC4

Q33826366-0F4ED60C-5D9D-4404-B9B9-EEF6D816244B

Q33826366-13F05641-6BA0-4AFA-A55D-ED842A366D25

Q33826366-17307DED-E08E-46E0-AFC8-D21C7A5D8F8D

Q33826366-22EA264A-FA20-438E-8572-87D81475C889

Q33826366-2834687E-164A-481A-B221-11D1E016784A

Q33826366-2A0A6FDD-1C9D-4CE0-9792-0BD57E6D8B8D

Q33826366-2C199B96-8EC4-49F0-9FCC-ADF6618ED959

P304

Q33826366-DEC18ECF-4E4E-4ADB-A04D-B7C262E723B0

P31

Q33826366-71A08959-1EC9-4B36-9213-282233FB67BD

P356

Q33826366-2FF81DC9-4720-4770-938C-574D48C26EBF

P407

Q33826366-D2926D06-F4E4-4344-AADA-450DD61E0F6E

P433

Q33826366-D2DEB345-4E5B-4CCB-957A-1BB40C3D11C7

P478

Q33826366-498FA292-F8DE-434B-922A-8DFA47985390

P577

Q33826366-6E570B66-E8A2-4873-A37C-5C4AADD644B1

P5875

Q33826366-65B3758D-D9DC-430A-B1C2-CC13354F9C3A

P698

Q33826366-0E97688C-2430-4BBE-AB0F-D55FE8FFCF69

P921

Q33826366-E3C009C8-3296-4FB5-81C4-E222FF5477C4

P932

Q33826366-7EEBA669-7243-49F4-BFE0-56CB8F9654FD

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics

@en

P2093

Matthew A Mulvey

http://www.w3.org/2001/XMLSchema#string

Matthew G Blango

http://www.w3.org/2001/XMLSchema#string

P2860

SOS response induces persistence to fluoroquinolones in Escherichia coli

Antibiotic resistance of bacteria in biofilms

Nitrofurantoin-induced pulmonary toxicity. In vivo evidence for oxidative stress-mediated mechanisms

Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group

Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding

Antibiotic susceptibility testing by a standardized single disk method

TLR4-mediated expulsion of bacteria from infected bladder epithelial cells.

Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.

Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

P304

1855-1863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00014-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41969042

http://www.w3.org/2001/XMLSchema#string

P698

20231390

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

P932

2863638

http://www.w3.org/2001/XMLSchema#string